Bringing decades of experience and strategic thinking to lead the members of the Mauna Kea Technologies team.
Mauna Kea Technologies has assembled a team of experts from various domains to overcome the hurdles that have impeded clinical research and treatment for decades. Along with their exceptional technical expertise, each member of our management team possesses the strong team building and organizational skills that enable Mauna Kea Technologies’ multidisciplinary approach to success and innovation.
SACHA LOISEAU, Ph.D.
President and CEO. Co-Founder
Sacha founded Mauna Kea Technologies in 2000 and has been the CEO ever since.
A co-inventor of the probe-based Confocal Laser Endomicroscopy technology, he piloted the development of the Cellvizio product line, raising over € 32 million with private investors until taking the company public in July 2011 on the NYSE Euronext Paris stock exchange.
In 2013, Sacha was named the co-lead of France's Re-industrialization Plan for Medical Devices by the French President and then a member of the Committee for the Future of Medicine. Sacha has served as a mentor to the Polytechnique-Stanford Ignite Program for young MedTech entrepreneurs for several years. Sacha was instrumental in the foundation of the association Medtech in France, of which he is Vice-President.
Sacha started his career at the National Center for Space Studies (CNES) in Toulouse and at the Paris Observatory, then joined NASA's Jet Propulsion Laboratory (JPL) in Pasadena, California, as a research scientist. Sacha has a Ph.D. in Astrophysics and Optical Instrumentation and is the author of multiple scientific articles and holds 7 international patents.
Global Director of Sales
Bruno has a rich, international background garnered from his studies in Lebanon, Italy and France where he became fluent in four languages.
Bruno started his career as an Export Area Manager for Sapag, a division of Saint-Gobain, then worked 15 years for Tyco Fire & Building Products where he was appointed General Manager of Asia-Pacific. In January of 2009, Bruno joined Mauna Kea Technologies with a mission to develop the Asia-Pacific market for Cellvizio. Since 2010, Bruno has been responsible for the deployment of Cellvizio in all territories and he now leads the global sales effort for Mauna Kea Technologies from Boston.
Christophe BAILLEUL, PhD, MBA
Vice-President Clinical Affairs, Health Economics and Market Access
Christophe joined Mauna Kea Technologies in 2015 and brings a wealth of clinical knowledge to the company with more than 25 years of international experience in the biotech and medical device sectors.
Christophe started his career in a French biotech startup affiliate of the National Blood Transfusion Foundation in the late 80s. He then spent 5 years in Germany as a research and quality assurance manager in a young CRO, PRA International. He also worked in the clinical development field at Ela Medical, which is part of Sorin Group. From 2002 on he was based in Belgium as the VP of Clinical Affairs and Health Economics of the International Division at St. Jude Medical.
Christophe holds multiple academic degrees including, an engineering degree from the Université de technologie de Compiègne in France, an MSc in blood transfusion and immunology, a PhD in immuno-biotechnologies and an MBA from ESSEC in Paris, France.
FRANÇOIS LACOMBE, Ph.D.
Chief Scientific Officer
François is a world-renowned scientist and the author of more than 150 scientific papers and 10 patents.
He spent 14 years working on major international astronomy projects such as ISOCAM, the Infrared SPace Observatory (ISO) satelite's on board camera, ADONIS, the first multi-user adaptive optics system and most recently NAOS, an adaptive optics system for the Very Large Telescope in Chile. François has been collaborating with Mauna Kea Technologies since its inception. François is a graduate of the École Normale Supérieure in Paris and holds a Ph.D. in Astrophysics.
VÉRONIQUE DENTAN, Ph.D.
Director of Operations
Véronique has invaluable experience in R&D, product design and engineering management on innovative products.
She began her carreer at the Thales Central Laboratory, first as a research engineer, then as Head of the Organic Materials laboratory. Véronique then went to Photonetics, a telecom company sold to GN NetTest in 2000, where she worked as Chief Technical Officer setting up and developping the R&D and engineering departments for Optical Components. Before joining Mauna Kea Technologies, Veronique also spent 2 years at IXsea, a French Company specialized in fiber-optics based inertial sensors where she was responsible for the OCTANS gyrocompass product line. Véronique is a graduate of the École Supérieure d'Optique in France and holds a Ph.D. in Non-Linear Optics.
|See how it all started, from Stars to Cells.|